Publications of Peter Seiler
All genres
Journal Article (24)
1.
Journal Article
44 (10), pp. 3760 - 3767 (2006)
Evaluation of peptide nucleic acid-fluorescence in situ hybridization for identification of clinically relevant mycobacteria in clinical specimens and tissue sections. Journal of Clinical Microbiology 2.
Journal Article
36 (3), pp. 631 - 647 (2006)
Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. European Journal of Immunology 3.
Journal Article
36 (3), pp. 631 - 647 (2006)
Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. European Journal of Immunology 4.
Journal Article
115 (9), pp. 2472 - 2479 (2005)
Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin. Journal of Clinical Investigation 5.
Journal Article
115 (9), pp. 2472 - 2479 (2005)
Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin. Journal of Clinical Investigation 6.
Journal Article
115 (9), pp. 2472 - 2479 (2005)
Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin. Journal of Clinical Investigation 7.
Journal Article
40 (6), pp. 448 - 452 (2005)
Decontamination with vaporized hydrogen peroxide is effective against Mycobacterium tuberculosis. Letters in Applied Microbiology 8.
Journal Article
205 (5), pp. 633 - 640 (2005)
Modified immunohistological staining allows detection of Ziehl-Neelsen-negative Mycobacterium tuberculosis organisms and their precise localization in human tissue. Journal of Pathology 9.
Journal Article
205 (5), pp. 633 - 640 (2005)
Modified immunohistological staining allows detection of Ziehl-Neelsen-negative Mycobacterium tuberculosis organisms and their precise localization in human tissue. Journal of Pathology 10.
Journal Article
85 (1-2), pp. 29 - 38 (2005)
Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis. Tuberculosis 11.
Journal Article
188 (9), pp. 1326 - 1331 (2003)
Cell-wall alterations as an attribute of Mycobacterium tuberculosis in latent infection. Journal of Infectious Diseases 12.
Journal Article
100 (22), pp. 12883 - 12888 (2003)
Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodies. Proceedings of the National Academy of Sciences of the United States of America 13.
Journal Article
33 (10), pp. 2676 - 2686 (2003)
Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokines. European Journal of Immunology 14.
Journal Article
33 (10), pp. 2676 - 2686 (2003)
Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokines. European Journal of Immunology 15.
Journal Article
171 (3), pp. 1148 - 1155 (2003)
Macrophages of the splenic marginal zone are essential for trapping of blood-borne particulate antigen but dispensable for induction of specific T cell responses. Journal of Immunology 16.
Journal Article
170 (10), pp. 5228 - 5234 (2003)
Neutrophilia in LFA-1-deficient mice confers resistance to listeriosis: Possible contribution of granulocyte-colony- stimulating factor and IL-17. Journal of Immunology 17.
Journal Article
170 (10), pp. 5228 - 5234 (2003)
Neutrophilia in LFA-1-deficient mice confers resistance to listeriosis: Possible contribution of granulocyte-colony- stimulating factor and IL-17. Journal of Immunology 18.
Journal Article
69 (12), pp. 7922 - 7926 (2001)
Limited mycobacterial infection of the liver as a consequence of its microanatomical structure causing restriction of mycobacterial growth to professional phagocytes. Infection and Immunity 19.
Journal Article
69 (12), pp. 7922 - 7926 (2001)
Limited mycobacterial infection of the liver as a consequence of its microanatomical structure causing restriction of mycobacterial growth to professional phagocytes. Infection and Immunity 20.
Journal Article
74 (13), pp. 5896 - 5901 (2000)
Additive effect of neutralizing antibody and antiviral drug treatment in preventing virus escape and persistence. Journal of Virology